Multiple myeloma
The VA rates Multiple myeloma under Diagnostic Code 7712 across 2 severity levels, from 0% to 100%. At 100%, veterans receive $3939/month or more in compensation.
Rating schedule — DC 7712 at a glance
- Minimum rating
- 0%
- Maximum rating
- 100%
- Rating tiers
- 2
- CFR section
- § 4.117
- Body system
- Hematologic & Lymphatic System
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
0%, 100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Multiple myeloma?
| Rating | Criteria |
|---|---|
| 0% | Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS) |
| 100% | Symptomatic multiple myeloma |
“Symptomatic multiple myeloma”
Common Questions About Multiple myeloma VA Ratings
What is the VA rating range for Multiple myeloma?
The VA rates Multiple myeloma under Diagnostic Code 7712 at 0%, 100%. The minimum 0% rating requires: Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS). The maximum 100% rating requires: Symptomatic multiple myeloma.
Which 38 CFR diagnostic code does the VA use for Multiple myeloma?
The VA rates Multiple myeloma under Diagnostic Code (DC) 7712, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
What is the difference between a 0% and a 100% rating for Multiple myeloma?
A 0% rating requires: Asymptomatic, smoldering, or monoclonal gammopathy of undetermined significance (MGUS). A 100% rating requires: Symptomatic multiple myeloma. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.
Can Multiple myeloma qualify for TDIU?
Yes — a 100% rating for Multiple myeloma alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.
What evidence supports a higher rating for Multiple myeloma?
The key evidence for Multiple myeloma is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Multiple myeloma?
The C&P examiner uses a Hematologic & Lymphatic System DBQ and evaluates your condition against the DC 7712 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits